CD8A and melanoma: Tumeh et al. 30reported that melanoma patients with liver metastases had a reduced density of CD8+ T cells at the invasive tumor margin in distant tumors compared with patients without liver metastases, which is associated with the response to a PD‐1 inhibitor.